Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00777062Phase 2Completed
Phase 2, randomised, double-blind trial of naltrexone in cocaine dependence and alcohol dependence, sponsored by University of Pennsylvania. Primary endpoint: Urine Assay for Benzoylecgonine at 8 weeks. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00777062.